New research suggests that delivering cannabidiol (CBD) through the nasal cavity using nanostructured lipid carriers (NLCs) may improve its effectiveness in treating epilepsy. Published in Molecular Pharmaceutics and conducted by researchers at Dalian University of Technology, the study aimed to bypass limitations of oral medications—such as first-pass metabolism and poor penetration through the blood-brain barrier—by … Continue reading Study: Intranasal CBD Nanocarriers May Improve Seizure Control and Brain Targeting